‌

US Patent 8835402 Compound and method for treating myotonic dystrophy

Patent 8835402 was granted and assigned to Sarepta Therapeutics on September, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Sarepta Therapeutics

0

Current Assignee

Sarepta Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Ryszard Kole0

Gunnar J. Hanson0

Date of Patent

September 16, 2014

0

Patent Application Number

140383140

Date Filed

September 26, 2013

0

Patent Citations Received

US Patent 12104156 Compositions and methods of treating facioscapulohumeral muscular dystrophy

0

US Patent 11872287 Compositions and methods of treating muscle atrophy and myotonic dystrophy

0

US Patent 11932851 Exon skipping compositions for treating muscular dystrophy

0

US Patent 11999955 Compositions and methods of treating facioscapulohumeral muscular dystrophy

0

0

US Patent 12064483 Nucleic acid-polypeptide compositions and methods of inducing exon skipping

0

US Patent 11707532 Compositions and methods of treating muscle dystrophy

0

US Patent 11712478 Compositions and methods of treating muscle atrophy and myotonic dystrophy

0

...

Patent Primary Examiner

Tracy Vivlemore

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8835402 Compound and method for treating myotonic dystrophy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.